Youngro Byun Selected Research

Angiogenesis Inhibitors

4/2016	Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
7/2015	Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 Inhibitor.
2/2015	Antiangiogenic and anticancer effect of an orally active low molecular weight heparin conjugates and its application to lung cancer chemoprevention.
1/2015	Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy.
10/2014	Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice.
8/2014	Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid.
3/2013	An apoptosis-homing peptide-conjugated low molecular weight heparin-taurocholate conjugate with antitumor properties.
12/2012	Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge.
11/2012	Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor.
12/2008	Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Youngro Byun Research Topics

Disease

82	Neoplasms (Cancer) 12/2022 - 10/2003
16	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2006
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 04/2007
8	Venous Thrombosis (Deep-Vein Thrombosis) 12/2016 - 06/2005
7	Thrombosis (Thrombus) 12/2014 - 09/2004
5	Type 2 Diabetes Mellitus (MODY) 01/2024 - 04/2013
5	Hypoxia (Hypoxemia) 01/2021 - 01/2012
5	Body Weight (Weight, Body) 08/2016 - 05/2006
5	Pulmonary Embolism 01/2016 - 06/2005
4	Osteoporosis 01/2022 - 12/2014
4	Hemorrhage 12/2016 - 05/2008
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2016 - 09/2006
3	Triple Negative Breast Neoplasms 10/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 01/2016
3	Breast Neoplasms (Breast Cancer) 11/2018 - 06/2009
3	Lung Neoplasms (Lung Cancer) 01/2018 - 06/2009
3	Inflammation (Inflammations) 10/2014 - 01/2002
3	Carcinogenesis 10/2014 - 05/2005
3	Venous Thromboembolism 12/2012 - 07/2007
3	Melanoma (Melanoma, Malignant) 12/2009 - 02/2008
3	Squamous Cell Carcinoma of Head and Neck 05/2005 - 04/2002
2	Wounds and Injuries (Trauma) 01/2019 - 01/2017
2	Cardiotoxicity 01/2019 - 01/2016
2	Fibrosis (Cirrhosis) 01/2016 - 01/2002
2	Multiple Myeloma 12/2014 - 02/2013
2	Diabetes Mellitus 01/2012 - 03/2006

Drug/Important Bio-Agent (IBA)

30	Heparin (Liquaemin)FDA LinkGeneric 11/2021 - 09/2004
17	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 06/2005
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 09/2006
11	ProdrugsIBA 12/2021 - 02/2015
11	AnticoagulantsIBA 01/2021 - 01/2006
10	Peptides (Polypeptides)IBA 01/2024 - 11/2007
10	Caspase 3 (Caspase-3)IBA 10/2022 - 02/2015
10	Angiogenesis InhibitorsIBA 04/2016 - 12/2008
9	Therapeutic UsesIBA 01/2019 - 02/2008
9	Deoxycholic Acid (Sodium Deoxycholate)IBA 10/2017 - 04/2007
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 07/2008
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2007
7	Taurocholic Acid (Sodium Taurocholate)IBA 11/2021 - 06/2012
7	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2010 - 06/2005
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2009
6	Protamines (Protamine Sulfate)FDA Link 10/2021 - 07/2012
5	AlbuminsIBA 10/2022 - 01/2016
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2016
5	Bile Acids and Salts (Bile Acids)IBA 04/2016 - 05/2006
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2006 - 04/2002
4	IntegrinsIBA 01/2022 - 11/2012
4	Cytotoxins (Cytolysins)IBA 01/2022 - 07/2018
4	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 10/2007
4	PolymersIBA 10/2017 - 02/2007
4	Enoxaparin (Lovenox)FDA LinkGeneric 12/2016 - 08/2006
4	Small Interfering RNA (siRNA)IBA 02/2014 - 06/2011
3	Pemetrexed (MTA)FDA Link 01/2022 - 01/2018
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 10/2016
3	CaspasesIBA 10/2021 - 01/2016
3	Ferritins (Ferritin)IBA 10/2021 - 10/2016
3	CytokinesIBA 01/2021 - 05/2012
3	Photosensitizing Agents (Photosensitizers)IBA 12/2019 - 05/2011
3	MicellesIBA 10/2017 - 11/2007
3	Celecoxib (Celebrex)FDA Link 07/2015 - 05/2005
3	Matrix Metalloproteinases (MMPs)IBA 02/2014 - 11/2007
3	glycol-chitosanIBA 02/2014 - 05/2011
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024 - 12/2017
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 08/2015
2	maleimideIBA 12/2021 - 01/2019
2	Cathepsin BIBA 12/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 02/2014
2	LigandsIBA 10/2021 - 01/2019
2	AntigensIBA 04/2020 - 10/2016
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2019 - 05/2011
2	Oxygen (Dioxygen)IBA 12/2019 - 01/2019
2	Insulin (Novolin)FDA Link 10/2019 - 12/2017
2	platelet-derived growth factor AIBA 01/2019 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 01/2017
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019 - 01/2017
2	HydrogelsIBA 01/2019 - 09/2014
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018 - 01/2013
2	Suramin (Suramin Sodium)IBA 01/2018 - 11/2015
2	Polysaccharides (Glycans)IBA 01/2018 - 05/2015
2	Poloxamer (Poloxamer 407)IBA 10/2017 - 06/2010
2	CollagenIBA 01/2015 - 11/2012
2	Drug CarriersIBA 02/2014 - 09/2006
2	Indicators and Reagents (Reagents)IBA 11/2013 - 11/2012
2	Exenatide (Byetta)FDA Link 11/2013 - 01/2013
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2013 - 11/2011

Therapy/Procedure

47	Therapeutics 01/2024 - 09/2006
14	Drug Therapy (Chemotherapy) 01/2022 - 02/2007
11	Oral Administration 12/2017 - 05/2006
7	Injections 12/2017 - 08/2006
6	Radiotherapy 01/2022 - 08/2015
5	Transplantation 01/2021 - 04/2007
5	Immunotherapy 01/2021 - 10/2016
4	Islets of Langerhans Transplantation 10/2019 - 04/2013
4	Intravenous Injections 01/2016 - 02/2007
4	Microspheres (Microsphere) 08/2006 - 01/2002
3	Chemoradiotherapy 01/2019 - 02/2015
3	Chemoprevention 02/2015 - 05/2005
3	Intravenous Administration 09/2014 - 06/2007
2	Photochemotherapy (Photodynamic Therapy) 12/2019 - 05/2011
2	Subcutaneous Injections 01/2016 - 12/2014